IQVIA Builds on its Strategic Collaboration with argenx to Provide Safety Systems and Services
03 Oktober 2023 - 2:00PM
Business Wire
IQVIA™ (NYSE:IQV), a leading global provider of advanced
analytics, technology solutions and clinical research services to
the life sciences industry, today announced a strategic
collaboration with argenx to advance treatment to patients with
rare autoimmune diseases through innovative and integrated
technology-enabled pharmacovigilance (PV) safety services and
solutions.
IQVIA’s integrated PV services and technology platforms will
support argenx to enable efficient integration of safety data and
adverse event identification and reporting, ultimately facilitating
the delivery of new therapies to patients. The integration of
safety data, operational processes and business acumen will support
argenx to scale its PV and safety organization alongside future
company growth. This builds on IQVIA and argenx’s existing
collaboration which focuses on the accelerated expansion of
clinical development and commercialisation of new indications.
“We look forward to collaborating closely with IQVIA on this
important business need. We aim to innovate in all that we do and
IQVIA’s technology-enabled PV services and solutions will allow for
efficient data integration as we work to bring new treatment
options to autoimmune patients,” commented Tim Van Hauwermeiren,
CEO, argenx.
“IQVIA is well positioned to support biotech clients such as
argenx through our extensive portfolio of services and technology
capabilities,” said Alistair Grenfell, President Europe, Middle
East, Africa and South Asia, IQVIA. “Our innovative solution will
help argenx transform and futureproof their existing PV and safety
organization, ultimately allowing them to get medicines to patients
as quickly as possible.”
IQVIA Connected Intelligence™ combines a leading solution with
data, advanced analytics, innovative technologies, and domain
expertise, enabling clients to uncover fresh insights and achieve
transformative change to succeed in rapidly evolving markets. The
collaboration with argenx brings together the IQVIA PV Safety and
Technology teams to create a unique solution to address their need
of consolidating, transforming and future-proofing PV operations in
the pre- and post-marketing space.
To learn more about IQVIA’s Pharmacovigilance solutions, visit
IQVIA.com for more information.
###
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry. IQVIA creates intelligent connections
across all aspects of healthcare through its analytics,
transformative technology, big data resources and extensive domain
expertise. IQVIA Connected Intelligence™ delivers powerful insights
with speed and agility — enabling customers to accelerate the
clinical development and commercialization of innovative medical
treatments that improve healthcare outcomes for patients. With
approximately 86,000 employees, IQVIA conducts operations in more
than 100 countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231003269129/en/
Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)
+1.973.316.3828
Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221
IQVIA (NYSE:IQV)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
Von Mai 2023 bis Mai 2024